About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Validation of French Version of LCADL and Dyspnea-12

Validation of French Version of LCADL and Dyspnea-12

NCT02555202·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Hospital, Brest

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

COPD with FEV1\< 50% of predictive value

You may not be if

FEV1\> 50% of predictive value
Patients with an exacerbation of COPD in the previous 30 days the inclusion

The record

StatusCompleted

PhaseNo phase

Taking part50

StartedOct 2015

UpdatedMar 31, 2017

Conditions

Where1

Brest University hospital
Morlaix, France